Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Oct 15, 2025, 8:00 PM EDT
Baudax Bio Revenue
Baudax Bio had revenue of $1.27 million in the twelve months ending September 30, 2023, up 217.25% year-over-year. In the year 2022, Baudax Bio had annual revenue of $1.27 million with 17.50% growth.
Revenue
1.27M
Revenue Growth
+217.25%
P/S Ratio
0.00
Revenue / Employee
141.00K
Employees
9
Market Cap
52.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 1.27M | 189.00K | 17.50% |
Dec 31, 2021 | 1.08M | 587.00K | 119.07% |
Dec 31, 2020 | 493.00K | - | - |
Dec 31, 2019 | - | - | - |
Dec 31, 2018 | - | - | - |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |